Boston Medical Center’s Pediatric Hematology and Oncology Program―part of BMC’s innovative Department of Pediatrics―offers state-of-the-art evaluation, diagnosis, treatment of blood disorders. Genetic abnormalities of the blood, such as sickle cell disease, are a main focus of the program, but it also provides evaluation and ongoing care for children and adolescents with a variety of blood disorders and “orphan” illnesses. Physicians are also available for second opinions related to leukemia or other childhood cancers.
Young patients receive exceptional, compassionate care from an expert, extended team of physicians, a nurse clinical coordinator, a social worker and a clinical child life specialist, all key resources for patients and families.
The program’s main focus is on children with inherited blood disorders, but it also provides evaluation and ongoing care for patients with a wide range of additional disorders affecting white blood cells, platelets and the bone marrow. Some of the diseases and disorders we treat include:
- Sickle cell anemia and related disorders
- Thalassemia, an amino acid imbalance
- Nutrition-related anemias
- Coagulation defects (bleeding and clotting disorders), such as hemophilia and von Willebrand disease
- Platelet disorders
- White cell disorders
- Histiocytic disease
- Autoimmune diseases affecting the blood
BMC’s Pediatric Hematology & Oncology Program helps patients and families with blood disorders